Flerlage JE, Eichenauer DA, Fuchs M, Hartmann S, Eich HT, Savage KJ, Lo AC, Skinnider B, Akhtar S, Rauf MS, Maghfoor I, Pinnix CC, Steiner R, Milgrom SA, Vega F, Alomari M, Zhang XY, Collins GP, Advani RH, Kumar P, Dickinson M, Wirth A, Tsang R, Prica A, Major A, Smith S, Hendrickson PG, Kelsey CR, Hopkins D, McKay P, Ng A, Koenig J, Constine LS, Casulo C, Sakthivel G, Baron J, Plastaras JP, Roberts KB, Gao S, Al Kendi J, Al Rahbi N, Balogh A, Levis M, Ricardi U, Sridhar A, Torka P, Specht L, De Silva R, Shah N, Pickard K, Osborne W, Blazin LJ, Henry M, Chang I, Smith CM, Halperin D, Miall F, Brady JL, Mikhaeel G, Brennan B, Penn A, Senchenko MA, Volchkov EV, Reeves M, Hoppe B, Terezakis S, Talaulikar D, Della Pepa R, Picardi M, Kirova Y, Fergusson P, Northend M, Hawkes E, Lee D, Doo NW, Barraclough A, Opat S, Cheah CY, Salvaris R, Ku M, Hamad N, Mutsando H, Tedjaseputra A, Gilbertson M, Marconi T, Viiala N, Palese M, Shankar A, Maurer MJ, Natkunam Y, Kelly KM, Borchmann P, Hoppe RT, Binkley MS. Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses. Blood Adv. 2026 Aug 11; 10(15):5338-5347.

Kakkar AK, Bonaca MP, Giugliano RP, Pieper K, Bloomfield D, Hug B, Salter J, Freedholm D, Parkar S, Virdone S, Prakasam HS, Fluharty M, Kayani G, Fox KAA. Contemporary patients with atrial fibrillation are not anticoagulated despite risks of stroke - Insights from GARDENIA. PLoS One. 2026; 21(7):e0354382.

Yang L, Gabriel N, Tang S, Cater L, Blackburn H, Page RL, Saba S, Hernandez I. Case-Crossover Analysis of Short-Term Particulate Matter and Health Outcomes in Patients With Atrial Fibrillation. J Am Heart Assoc. 2026 Aug 04; 15(15):e046917.

Al-Samkari H, Friday C, Kasthuri RS, Gossage JR, Murphy CG, Hountras P, Smith KL, Kirkland K, Iyer V, Prasad V, Ahluwalia V, Rodriguez-Lopez J, Witkin AS, Conrad M, Hetts S, Ohliger M, Chakinala M, Sisk BA, Beasley MA, Kirkpatrick P, Lindquist J, Battaile JT, Lu A, Parambil J, McCrae K, Sheynzon V, Whitehead K, Sion C, McWilliams J, Cusumano LR, Trerotola SO, Drivas TG, Chesnutt M, Kaufman C, Dickey M, Boyce D, Krock N, Cottrill C, Competiello T, Levy H, Clancy M, Henderson K, Pollak JS. Clinical spectrum of hereditary hemorrhagic telangiectasia: data from the Comprehensive HHT Outcomes Registry of the US (CHORUS). Blood. 2026 Jul 23; 148(4):417-432.

Galsky MD, Valderrama BP, Maruzzo M, Font A, Ciuleanu T, Chatzkel J, Koie T, Hoimes CJ, Puente J, Zakharia Y, Rosenbaum E, Boehm K, Loriot Y, Bedke J, Powles TB, Necchi A, Wiechno P, Álvarez-Fernández C, Kim TH, Oliveira N, Flaig TW, Wirtz HS, Mihm M, Huang Q, Rogiers A, Homet Moreno B, Gómez de Liaño A. Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer. N Engl J Med. 2026 Jul 23; 395(4):338-348.

Sweis RF, Melero I, Davar D, Garralda E, Hamid O, Chen HA, Evans TRJ, Moore KN, Sacco JJ, Thistlethwaite F, Williams A, Blumenschein GR, Callahan MK, Johnson ML, Schenk EL, Wustner J, Stanhope S, Tao K, Marshall S, Lopez J. Phase 1/2 study of IMC-C103C, a T cell receptor bispecific (MAGE-A4×CD3) ImmTAC targeting MAGE-A4-expressing malignancies. J Immunother Cancer. 2026 Jul 20; 14(7).

Aboul-Nour H, Siegler JE, Thompson SL, Glover PA, Daniel JA, Penckofer M, Smith MM, Yaghi S, Ro J, Chen L, D'Souza M, Khasiyev F, Kerrigan D, Sharma R, Aziz YN, Kirchhoffer K, Kam W, Melkumova E, Sloane KL, Lineback CM, Thottempudi N, Heaton S, Linares G, Singh E, Almallouhi E, Stretz C, Albert Fernandez CJ, Dumitrascu OM, Culbertson CJ, Elangovan C, Bowman A, Valhuerdi Porto C, Chahien D, Herpich F, Farooqui M, Kang J, de Havenon A, Nelson A, Shahrivari M, Stamm B, Khezri N, Lewis S, Sathya A, Leung LY, Eklund K, Rojas-Soto D, Nedelcu S, Al Kasab S, Van Coevering RJ, Thon J, Jillella DV, Nahab FB. Real-World Practice in Secondary Stroke Prevention Following Embolic Stroke of Undetermined Source: Secondary Analysis of the CASPR Registry. Neurol Clin Pract. 2026 Aug; 16(4):e200631.

Gohil S, Omar M, Carnes ML, Karlitz JJ, Usry N, Idriss R, Greene M. Adherence to multi-target stool DNA colorectal cancer screening among Medicare patients in Alabama. Curr Med Res Opin. 2026 May; 42(5):941-951.

Erlandson KM, Gustafson L, Johnson JE, Kulik GL, Khuu V, Chahal N, Walpert AR, Galdamez ME, Zorgno I, Foldyna B, Jarraya M, Reusch JE, Lee H, Grinspoon SK, Jankowski CM, Fourman LT. Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH): a clinical trial protocol. BMJ Open. 2026 Jul 08; 16(7):e120740.

Lensink-Vasan M, Wham C, Nicke D, Espinoza I, Duenas J, Kuna EM, Sillau S, Farcas A, Dylla L. Association between race, ethnicity, and sex with prehospital identification and outcomes of patients with stroke. J Stroke Cerebrovasc Dis. 2026 Aug; 35(8):108696.